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Conclusion: We can improve treatment-plan quality for lung 
SBRT treatments by providing the planner with a quality 
parameter associated with the dose gradient around the PTV. 
This index does not depend on GTV volume and position and 
is suited to compare all patients treated for SBRT without 
making corrections for size and position of the tumor and is 
suitable for multiple tumors. 
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Purpose or Objective: In recent years 
Magnetoencephalography (MEG) and Functional Magnetic 
Resonance Imaging (fMRI) have imposed as non-invasive 
methods providing localization of eloquent brain areas for 
pre-surgical planning. With the advent of radiosurgery, the 
impact of these neuroimaging techniques in preventing 
neurological morbidity is under investigation in the clinical 
conditions for which radiotherapy is the treatment of choice. 
This study aimed to develop a method of integrating MEG and 
fMRI maps into a Cyberknife system to optimize dose 
planning. 
 
Material and Methods: A patient with a recurrent brain 
metastasis affecting both the left pre-central and the post-
central gyrus underwent functional imaging of the hand 
motor cortex two weeks prior its scheduled radiosurgery 
treatment. MEG data were acquired with a 306 sensors 
whole-head system while the patient performed self-paced 
motor activation of right hand and index finger. Epochs were 
extracted in the window ranging from – 3 to +3 seconds with 
respect to the movement onset and then averaged. Source of 
the motor-related activity was assessed by means of 
swLORETA algorithm. A day after MEG acquisition, fMRI was 
performed using a 3T MR Philips Achieva scanner. Motor 
activation of right hand and index finger was obtained 
through a block designed paradigm. Stimulation modality and 
duration both for MEG and fMRI were chosen to maximize 
time course signal to noise ratio. Magnetoencephalography 
and fMRI maps were integrated into a Cyberknife system for 
treatment planning optimization, considering the boolean 
sum of activations as organ at risk. 
 
Results: Localization of the hand motor cortex was obtained 
for both functional investigation methods within close 
proximity of the lesion.  
Integration of the fMRI data into the Cyberknife system was 
easily achieved through the customary Cyberknife import 
protocol.  
More problematic was the integration of the MEG images, and 
for the purpose a customized Dicom import software had to 
be developed.  
 
 
 
Figure show the results of the MEG and fMRI functional areas 
implemented into the Cyberknife system: the fMRI area 
(indicated in yellow) and the MEG area (indicated in green) 
result partially overlapped. 
Only small differences were observed between MEG and fMRI 
activation areas after image co-registration.  
Inclusion of the activation area into the plan optimization 
process allowed a reduction of 19% of the mean dose to the 
motor cortex 
 
Conclusion: Nowadays, the availability of advanced 
neuroimaging techniques is playing a more and more 
important role in radiosurgical planning strategy. The authors 
developed an effective method to co-register fMRI and MEG 
data sets in a Cyberknife treatment planning system.  
This additional information can improve dose sparing of 
eloquent areas, and MEG information in particular might be 
valuable when BOLD effect is disturbed by pathological 
vascularization. 
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Purpose or Objective: The strong directional characteristics 
of step-and-shoot IMRT beams, and the ability to turn off the 
beam between segments, may be used to advantage when 
avoiding critical structures. Consequently, there may be a 
benefit in delivering selected parts of VMAT plans using IMRT 
beams. This study investigates such a hybrid approach for the 
case of prostate radiotherapy. 
 
Material and Methods: Five prostate patients were 
retrospectively studied. The AutoBeam treatment planning 
system produced hybrid IMRT / VMAT plans with a prescribed 
mean dose of 74 Gy in 37 fractions to the smallest of three 
target volumes, PTV74Gy, PTV71Gy and PTV60Gy. Inverse 
planning consisted of fluence optimisation using iterative 
least squares, sequencing, and aperture optimisation. The 
plans consisted of a single 220º arc with 111 segments 
arranged in groups of 20°. For each patient, five hybrid IMRT 
/ VMAT plans were constructed, with 0%, 25%, 50%, 75% and 
100% of the segment groups sequenced for IMRT, 
respectively, and the remainder of the segment groups 
sequenced for VMAT, maintaining the same number of beam 
segments in all cases. Thus, 0% IMRT corresponded to 
conventional VMAT and 100% IMRT corresponded to an 11-
beam IMRT plan. IMRT groups were selected on the basis of 
fluence variation in each group, the most complex fluence 
maps being selected for IMRT delivery at the central gantry 
angle of the group. Treatment plans were evaluated in terms 
of PTV dose uniformity (root-mean-square variation) and 
coverage, critical structure dose, objective value and 
monitor units. All plans were then delivered as single hybrid 
beams to a water-equivalent phantom using an Elekta 
Synergy accelerator with Agility head, and the delivery time 
recorded. The dose measured using a Farmer ionisation 
chamber at the centre of the phantom within PTV74Gy was 
compared with the planned dose. Data were demonstrated by 
quantile-quantile plots to be normally distributed and 
compared to the 0% IMRT case using paired Student t-tests. 
 
Results: All plans are clinically acceptable, but increasing the 
IMRT percentage improves PTV coverage (p < 0.01 for 50% or 
more), reduces the volume of rectum irradiated to 65 Gy (p < 
0.01) and increases the monitor units (p < 0.001) (Table 1). 
Delivery time also increases substantially, which is clinically 
relevant due to prostate motion being partly dependent on 
treatment time. All plans show accurate delivery of dose. 
.  
 
Conclusion: Hybrid IMRT / VMAT can be efficiently planned 
and delivered as a single beam sequence. Beyond 25% IMRT, 
the delivery time becomes unacceptably long, outweighing 
the benefit of the improved plan quality, but 25% IMRT is an 
attractive compromise. These hybrid plans can be accurately 
delivered. 
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Purpose or Objective: Dynamic Wave Arc (DWA) is a clinical 
approach designed to maximize the versatility of Vero SBRT 
system by synchronizing the gantry-ring noncoplanar 
movement with D-MLC optimization. The purpose of this 
study was to verify the delivery accuracy of DWA approach 
for SBRT treatments and to evaluate the potential dosimetric 
benefits. 
 
Material and Methods: A preclinical version of RayStation 
v4.7 (RaySearch Laboratories, Sweden) was used to create 
patient specific wave arc trajectories. DWA is an extended 
form of VMAT with a continuous varying ring position. The 
main difference in the optimization modules of VMAT and 
DWA is during the angular spacing, where the DWA algorithm 
does not consider the gantry spacing, but only the Euclidian 
norm of the ring and gantry angle that cannot exceed 4°. 
Thirty-one patients with various anatomical tumor regions 
were selected from the Vero patient database. It was 
decided to select some pathologies with a high incidence 
(prostate and oligometastases) and some more challenging 
cases from the perspective of organ-at-risk sparing i.e. 
centrally-located non-small cell lung cancer (NSCLC) tumors 
and locally-advanced pancreatic cancer (LAPC). DWA was 
benchmarked against the current clinical approaches and 
coplanar VMAT to establish the clinical importance of DWA 
among other treatment approaches. Each plan was evaluated 
with regards to the target coverage, dose to OAR, MU 
efficiency and treatment delivery time. The delivery 
accuracy was evaluated using the Delta4 2D diode array that 
takes in consideration the multi-dimensionality of DWA. 
 
Results: For prostate and oligometastases, the results 
showed that all modalities provide comparable plan quality, 
with no significant difference for PTV coverage or OAR 
sparing, but with a steeper dose gradient outside the target 
for DWA. The delivery time per lesion was significant reduced 
with DWA (Table 1). For centrally-located NSCLC (Figure 1), 
DWA and VMAT increased target coverage and conformity. 
The structures that significantly benefited from using DWA 
were proximal bronchus (Dmax 24.72Gy, 20.57Gy and 
22.75Gy) and esophagus (16.6Gy, 12.57Gy and 14.76Gy) for 8-
10CRT beams, DWA and VMAT, respectively. The other OARs 
presented comparable values. In the LAPC cases, DWA 
achieved similar PTV coverage, along with a significantly 
improved GTV coverage and improved low dose spillage 
(p<0.01). The delivery time and the number of MU needed to 
deliver the dose were significantly lower for DWA versus 
IMRT. The DWA plans presented a good agreement between 
measured and calculated dose, with an mean ɣ (3%,3mm) 
passing rate of 98.17%, 98.72%, 99.2% and 98.1% for the 
prostate, oligometatstatic cases, centrally-located NSCLC and 
LAPC, respectively. 
